The incidence of asthma and allergic rhinitis among young adults in 12 year follow-up Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017
Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005
Tiotropium improved asthma symptoms and increased time to first exacerbation in patients with moderate-to-severe asthma. Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020
Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Persistent airway inflammation in young allergic wheezing children treated with inhaled corticosteroids Source: Annual Congress 2003 - Current issues on wheezing in infancy Year: 2003
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Can response to inhaled corticosteroids in preschool children with recurrent wheezing predict asthma at age six years? Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012
The effect of inhaled corticosteroids on lung function in pre-school children with asthma-like symptoms in general practice: the ASTERISK study Source: Eur Respir J 2004; 24: Suppl. 48, 164s Year: 2004
Efficacy of high dose inhaled DSCG on asthma control in young children Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma Source: Eur Respir J, 55 (1) 1900964; 10.1183/13993003.00964-2019 Year: 2020
Twenty-four weeks of lansoprazole reduces asthma exacerbations and improves asthma quality of life in subjects with symptoms of acid reflux Source: Eur Respir J 2002; 20: Suppl. 38, 50s Year: 2002
The effect of inhaled corticosteroids on symptoms in pre-school children with asthma-like symptoms in general practice: the ASTERISK study Source: Eur Respir J 2004; 24: Suppl. 48, 165s Year: 2004
Budesonide/formoterol for maintenance and relief in adolescents with asthma: fewer exacerbations and improved asthma control Source: Eur Respir J 2004; 24: Suppl. 48, 164s Year: 2004
Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021
Early patterns of wheezing in asthmatic and nonasthmatic children Source: Eur Respir J 2013; 42: 1020-1028 Year: 2013
Perceived asthma control and cold air exercise induced airway obstruction in children aged 9–16 years Source: Eur Respir J 2006; 28: Suppl. 50, 479s Year: 2006
Montelukast and budesonide therapy of asthmatic patients suffering from chronic cough Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006
Outcome of childhood asthma in 105 asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 334s Year: 2002